Primary biliary cholangitis, symptoms affect quality of life: a holistic approach is needed

Conforti ok

Primary biliary cholangitis, from research to listening: a commitment to 360° care

D'Antona Interview

Breast cancer, genomic tests still underutilized: greater uniformity needed in Italy

Breast cancer, genomic tests on biopsies to guide treatment decisions before surgery

Interview with Criscitiello

The Future of Healthcare: Local Care, Innovation, and Collaboration for a Sustainable National He...

Healthcare of the future, more public-private collaboration for innovation and access

Digital Health, From Innovation to Practice: How to Bring AI and Telemedicine into the National H...

ESC Guidelines on Cardiac Amyloidosis with Dr. D'Elia

Interview with Dr. Cappelli

Hypertrophic cardiomyopathy: what to do for the non-obstructive form?

ESC Schieri

ESC Geraci

ESC Crea

De Ferrari interview 1

LDL Cholesterol, intervening before a heart attack: new evidence from the VESALIUS-CV study

ESC Guidelines

Interview with Dr. Maggioni

Interview with Dr. Bilato on statins

Interview with Bilato on evolocumab

Di Fusco Interview

Interview with Volpe

Interview with Cianflone

ESC DeLuca

De Luca heart and kidneys interview

Megna

Costanzo2

Costanzo 1

Emmi Interview

Interview with Stocchi

PINTO INTERVIEW ECONOMICS AND PHARMACEUTICAL POLICY ROME 06/17/26 REDONE

MALAPELLE INTERVIEW: PHARMACEUTICAL ECONOMICS AND POLICY ROA 06/26/17 REVISED

NORMANNO INTERVIEW ECONOMICS AND PHARMACEUTICAL POLICY ROME 06/26/17 REDONE

GIULIANI INTERVIEW: ECONOMY AND PHARMACEUTICAL POLICY ROA 06/26/17 Reworked

INTERVIEW WITH JOMMI: ECONOMICS AND PHARMACEUTICAL POLICY ROME 06/17/26 REMADE

DI NOVI INTERVIEW ON PHARMACEUTICAL ECONOMICS AND POLICY ROA 06/17/26 REMAKE

INTERVIEW WITH POPOLI: ECONOMICS AND PHARMACEUTICAL POLICY

INTERVIEW WITH PAPPAGALLO: ECONOMICS AND DRUG POLICY

INTERVIEW WITH MARCELLUSI: PHARMACEUTICAL ECONOMICS AND POLICY

INTERVIEW WITH SILANO: PHARMACEUTICAL ECONOMICS AND POLICY

INTERVIEW WITH BUZZETTI: PHARMACEUTICAL ECONOMICS AND POLICY

Tumore del polmone, perché le cure non funzionano per tutti? Le sfide ancora aperte

Psoriasis, anti-IL-23: Toward controlling systemic inflammation and disease progression

Psoriasis: Why early intervention matters—the role of systemic inflammation and comorbidities

Clinical research in rare diseases: methodological rigor and new perspectives

Rare diseases: New challenges for healthcare assessment and planning

MASH, from fatty liver to cirrhosis: how to recognize and stop the disease

Vitiligo: Improving Patient-Centered Care to Enhance Quality of Life and Treatment Access

Vitiligo, therapeutic and organizational innovation: the value of stakeholder collaboration

Pharmacy Services and Teledermatology: Lombardy Trial Strengthens Care for Vitiligo

Vitiligo, new targeted therapies and adherence: the keys to improving clinical results

Telemedicine and community pharmacies: Lombardy pilots a care model for vitiligo

Transthyretin cardiac amyloidosis, new treatment prospects from clinical research

MASH: How is the most severe form of fatty liver disease diagnosed?

Breast Cancer: How the Clinical Pathway Evolves with Precision Medicine and Survivorship

Aortic stenosis, planning TAVI with future treatments in mind

Aortic stenosis, in complex cases experience and TAVI planning increase safety

Disability: Moving Beyond Physical and Cultural Barriers to Live Freely